TREA

98291104 - ONCOTIME

Follow

Information

  • Trademark
  • 98291104
  • Serial Number
    98291104
  • Filing Date
    November 29, 2023
    a year ago
  • Transaction Date
    February 13, 2025
    27 days ago
  • Status Date
    February 13, 2025
    27 days ago
  • Published for Opposition Date
    June 18, 2024
    8 months ago
  • Location Date
    August 13, 2024
    7 months ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CASTRO, GIANCARLO
  • Attorney Docket Number
    189898.00055
    Attorney Name
    Christopher D. Olszyk, Jr.
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
3
Mark Identification
ONCOTIME
Case File Statements
  • DM0000: The mark consists of the wording "Onco" in blue followed by "TIME" in orange and wherein the inner circle of the first letter "O" contains a series of orange balls being five larger balls and 12 smaller balls randomly placed; the color white is not part of the mark but represents background or shading.
  • GS0051: Research use only chemical reagents for clinical medical or veterinary purposes; diagnostic reagents for medicinal research use
  • PM0001: ONCO TIME
  • CC0000: The color(s) blue and orange is/are claimed as a feature of the mark.
  • GS0011: Diagnostic reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
  • GS0101: Research use only biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Research use only cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; Research use only cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; Research use only medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient
  • GS0421: Providing reagent sample testing and diagnostic services for others in the field of cancer testing research, tumor testing research, and screening for the purpose of evaluating patient immunotherapy cancer treatment options
Case File Event Statements
  • 11/29/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/28/2024 - a year ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM
  • 2/28/2024 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/29/2024 - 11 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/1/2024 - 11 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/1/2024 - 11 months ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/1/2024 - 11 months ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/8/2024 - 10 months ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/8/2024 - 10 months ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/9/2024 - 10 months ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/9/2024 - 10 months ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/29/2024 - 9 months ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/18/2024 - 8 months ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/18/2024 - 8 months ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/13/2024 - 7 months ago
    15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 2/12/2025 - 28 days ago
    16 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 2/13/2025 - 27 days ago
    17 - SOU EXTENSION 1 FILED Type: EXT1
  • 2/13/2025 - 27 days ago
    18 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 2/13/2025 - 27 days ago
    19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA